ATE341337T1 - P-selectin zeilgerichtetenligand und dessen zusammenstezung - Google Patents
P-selectin zeilgerichtetenligand und dessen zusammenstezungInfo
- Publication number
- ATE341337T1 ATE341337T1 AT04735558T AT04735558T ATE341337T1 AT E341337 T1 ATE341337 T1 AT E341337T1 AT 04735558 T AT04735558 T AT 04735558T AT 04735558 T AT04735558 T AT 04735558T AT E341337 T1 ATE341337 T1 AT E341337T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- group
- optionally substituted
- moiety
- selectin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20030012123 EP1481683A1 (de) | 2003-05-30 | 2003-05-30 | P-Selectin Zeilgerichtetenligand und dessen Zusammenstezung |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE341337T1 true ATE341337T1 (de) | 2006-10-15 |
Family
ID=33104110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04735558T ATE341337T1 (de) | 2003-05-30 | 2004-06-01 | P-selectin zeilgerichtetenligand und dessen zusammenstezung |
Country Status (8)
Country | Link |
---|---|
US (1) | US8003596B2 (de) |
EP (2) | EP1481683A1 (de) |
JP (1) | JP4771291B2 (de) |
AT (1) | ATE341337T1 (de) |
CA (1) | CA2527438A1 (de) |
DE (1) | DE602004002699T2 (de) |
ES (1) | ES2273260T3 (de) |
WO (1) | WO2004105783A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ577604A (en) | 2006-11-15 | 2012-06-29 | Arthritis Relief Plus Ltd | Topical formulation and uses thereof |
EP2111218B1 (de) * | 2007-01-24 | 2014-07-02 | Syddansk Universitet | Dna-kontrollierte anordnung von lipidmembranen |
HUE059078T2 (hu) * | 2009-02-20 | 2022-10-28 | Enhanx Biopharm Inc | Glutation-alapú hatóanyagszállító rendszer |
JP2016160248A (ja) * | 2015-03-05 | 2016-09-05 | 国立大学法人京都大学 | 糖誘導体、またはその塩、セレクチン結合剤、糖結合体、粒子状キャリア、および輸送方法 |
US20220339289A1 (en) * | 2021-04-20 | 2022-10-27 | Bicycletx Limited | Bicyclic peptide ligands specific for p-selectin |
CN113616810A (zh) * | 2021-08-11 | 2021-11-09 | 南开大学 | 一种靶向p-选择素的工程化细胞外囊泡组合物及其制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1070047A2 (de) | 1998-04-08 | 2001-01-24 | Celltech Chiroscience Limited | Lipide |
GB9919338D0 (en) | 1999-08-16 | 1999-10-20 | Celltech Therapeutics Ltd | Biological products |
US6656448B1 (en) | 2000-02-15 | 2003-12-02 | Bristol-Myers Squibb Pharma Company | Matrix metalloproteinase inhibitors |
NO20004795D0 (no) | 2000-09-26 | 2000-09-26 | Nycomed Imaging As | Peptidbaserte forbindelser |
EP1337278A2 (de) * | 2000-11-27 | 2003-08-27 | Bristol-Myers Squibb Medical Imaging, Inc. | Gleichzeitiges imaging der kardialen perfusion und eines auf den vitronektin rezeptor zielgerichteten agens |
US20040241222A1 (en) * | 2001-06-01 | 2004-12-02 | Metselaar Josbert Maarten | Lipid-polymer-conjugates compositions |
EP1288222A1 (de) * | 2001-09-03 | 2003-03-05 | Yamanouchi Europe B.V. | Selektiv P-Selectin bindende peptidische Verbindungen |
-
2003
- 2003-05-30 EP EP20030012123 patent/EP1481683A1/de not_active Withdrawn
-
2004
- 2004-06-01 JP JP2006529953A patent/JP4771291B2/ja not_active Expired - Fee Related
- 2004-06-01 WO PCT/EP2004/005873 patent/WO2004105783A1/en active Application Filing
- 2004-06-01 ES ES04735558T patent/ES2273260T3/es not_active Expired - Lifetime
- 2004-06-01 AT AT04735558T patent/ATE341337T1/de not_active IP Right Cessation
- 2004-06-01 EP EP04735558A patent/EP1638588B1/de not_active Expired - Lifetime
- 2004-06-01 DE DE602004002699T patent/DE602004002699T2/de not_active Expired - Lifetime
- 2004-06-01 CA CA002527438A patent/CA2527438A1/en not_active Abandoned
- 2004-06-01 US US10/558,492 patent/US8003596B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20070185348A1 (en) | 2007-08-09 |
EP1481683A1 (de) | 2004-12-01 |
CA2527438A1 (en) | 2004-12-09 |
WO2004105783A1 (en) | 2004-12-09 |
ES2273260T3 (es) | 2007-05-01 |
EP1638588A1 (de) | 2006-03-29 |
JP2007500200A (ja) | 2007-01-11 |
JP4771291B2 (ja) | 2011-09-14 |
DE602004002699D1 (de) | 2006-11-16 |
DE602004002699T2 (de) | 2007-08-16 |
EP1638588B1 (de) | 2006-10-04 |
US8003596B2 (en) | 2011-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Dynamic covalent polymers for biomedical applications | |
Thornton et al. | Enzyme‐responsive polymer hydrogel particles for controlled release | |
JP5424531B2 (ja) | ジペプチドまたはジペプチド誘導体の製造法 | |
JP5441693B2 (ja) | 新規脂質ペプチド並びにヒドロゲル | |
Ashton et al. | Amino acid derivatives of β-cyclodextrin | |
CY1110612T1 (el) | Φαρμακευτικες συνθεσεις για την παρατεταμενη απελευθερωση δραστικης ουσιας (ουσιων) καθως και οι εφαρμογες αυτων και κυριως οι θεραπευτικες | |
US7829337B2 (en) | Cell-releasing agent and method of releasing cell sheet | |
Mertz et al. | Ultrathin, bioresponsive and drug-functionalized protein capsules | |
RU2007103811A (ru) | Пептидные антибиотики и способы их получения | |
US20220127565A1 (en) | A Self-Assembling Short Amphiphilic Peptide And Related Methods And Uses | |
ATE341337T1 (de) | P-selectin zeilgerichtetenligand und dessen zusammenstezung | |
KR20070073008A (ko) | 조직재생을 위한 히알루론산-기초된 주사형 하이드로겔 | |
WO2005026375A3 (en) | Recombinant carrier molecule for expression, delivery and purification of target polypeptides | |
Beyer et al. | Low fouling peptides with an all (D) amino acid sequence provide enhanced stability against proteolytic degradation while maintaining low antifouling properties | |
JP5424530B2 (ja) | ジペプチドまたはジペプチド誘導体の製造法 | |
Bernhard et al. | Spectrophotometric and structural evidence as to the mechanism of protease catalysis at chemical bonding resolution | |
WO2004081033A3 (en) | Synthesis of proteins by cell-free protein expression | |
RU2184114C2 (ru) | Новые производные бензоксазиндиона и лекарственный препарат на их основе | |
O'Donovan et al. | A photocleavable linker for the chemoselective functionalization of biomaterials | |
CA2139350A1 (en) | Oxazolone derived materials | |
US20100093084A1 (en) | Method for creating intracellular artificial nanostructures in situ | |
JP6099756B2 (ja) | ペプチド又はタンパク質へのフッ素含有アミノ酸導入法 | |
US20170022487A1 (en) | Synthetic catalytic mimics of esterases, lipases or desaturases | |
FR3032202A1 (fr) | Matrice sous forme de bille comme support cellulaire | |
Albers et al. | Benzotriazole-based strategies toward peptidomimetics, conjugates, and other peptide derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |